NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.verified

NRSN

Price:

$1.167

Market Cap:

$20.23M

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.[Read more]

Industry

Biotechnology

IPO Date

2021-12-09

Stock Exchange

NASDAQ

Ticker

NRSN

The PE Ratio as of May 2024 (TTM) for NeuroSense Therapeutics Ltd. (NRSN) is -1.41

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -1.41. This represents a change of 2.31% compared to the average of -0.06 of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSN) Historical PE Ratio (quarterly & annually)

How has NRSN PE Ratio performed in the past?

The mean historical PE Ratio of NeuroSense Therapeutics Ltd. over the last ten years is -2.66. The current -1.41 PE Ratio has changed 5.21% with respect to the historical average. Over the past ten years (40 quarters), NRSN's PE Ratio was at its highest in in the September 2023 quarter at 3.08. The PE Ratio was at its lowest in in the December 2021 quarter at -66.64.

Quarterly (TTM)
Annual

Average

-2.66

Median

-1.91

Minimum

-6.39

Maximum

-0.95

NeuroSense Therapeutics Ltd. (NRSN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -0.95

Minimum Annual Increase = -56.63%

Minimum Annual PE Ratio = -6.39

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.95-24.27%
2022-1.25-34.50%
2021-1.91-30.96%
2020-2.77-56.63%

NeuroSense Therapeutics Ltd. (NRSN) Average PE Ratio

How has NRSN PE Ratio performed in the past?

The current PE Ratio of NeuroSense Therapeutics Ltd. (NRSN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.37

5-year avg

-2.66

10-year avg

-2.66

NeuroSense Therapeutics Ltd. (NRSN) PE Ratio vs. Peers

How is NRSN’s PE Ratio compared to its peers?

NeuroSense Therapeutics Ltd.’s PE Ratio is less than Quoin Pharmaceuticals, Ltd. (-0.18), less than Revelation Biosciences, Inc. (-0.22), less than Hillstream BioPharma, Inc. (-0.00), less than NeuroBo Pharmaceuticals, Inc. (-1.27), less than Virax Biolabs Group Limited (-0.23), greater than Nutriband Inc. (-7.62), less than Longeveron Inc. (-0.13), greater than RenovoRx, Inc. (-2.34), less than Blue Water Vaccines, Inc. (-0.17), less than Kiora Pharmaceuticals, Inc. (5.04), less than PaxMedica, Inc. Common Stock (-0.01), less than Allarity Therapeutics, Inc. (-0.01), less than Kiromic BioPharma, Inc. (-0.19), less than Biodexa Pharmaceuticals Plc (-0.15),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is NeuroSense Therapeutics Ltd.'s PE Ratio?

How is the PE Ratio calculated for NeuroSense Therapeutics Ltd. (NRSN)?

What is the highest PE Ratio for NeuroSense Therapeutics Ltd. (NRSN)?

What is the 3-year average PE Ratio for NeuroSense Therapeutics Ltd. (NRSN)?

What is the 5-year average PE Ratio for NeuroSense Therapeutics Ltd. (NRSN)?

How does the current PE Ratio for NeuroSense Therapeutics Ltd. (NRSN) compare to its historical average?